Clinical Trial Update: Thrombolysis in Myocardial Ischemia Trial (TIMI III) [Phase 3]

View source ↗

Summary

The Phase 3 TIMI III trial evaluating thrombolysis in myocardial ischemia has completed, with an update posted on the trial registry.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Angina Pectoris
• Coronary Artery Disease
• Myocardial Infarction
• Myocardial Ischemia

Snippet

Sponsor: National Heart, Lung, and Blood Institute (NHLBI) | Conditions: Angina Pectoris, Cardiovascular Diseases | Phase 3 | Status: COMPLETED